Octagon Capital Advisors LP / CDTX
Octagon Capital Advisors LP’s Cidara Therapeutics Inc Position
Does Octagon Capital Advisors LP own Cidara Therapeutics Inc (CDTX)? Not currently — the last reported position was 100.0K shares worth $22M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$22M
Q4 2025
Shares
100.0K
% of Portfolio
+2.68%
Quarters Held
2
position exited
Position History CDTX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of CDTX.